Health Care & Life Sciences » Pharmaceuticals | Apeloa Pharmaceutical Co. Ltd.

Apeloa Pharmaceutical Co. Ltd. A | Income Statement

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
3,900
4,233
4,337
4,729
5,499
6,330
Cost of Goods Sold (COGS) incl. D&A
3,081
3,202
3,224
3,512
3,904
4,434
Gross Income
819
1,031
1,114
1,217
1,595
1,896
SG&A Expense
544
640
743
900
1,194
1,456
EBIT
242
367
328
307
373
421
Unusual Expense
-
1
51
5
4
37
Non Operating Income/Expense
21
73
23
74
16
102
Interest Expense
82
84
68
64
63
43
Pretax Income
206
377
246
333
336
446
Income Tax
45
50
39
72
83
92
Equity in Affiliates
-
-
1
2
4
16
Consolidated Net Income
161
327
208
263
257
371
Net Income
167
322
208
263
257
371
Net Income After Extraordinaries
167
322
208
263
257
371
Net Income Available to Common
167
322
208
263
257
371
EPS (Basic)
0.16
0.30
0.18
0.23
0.22
0.31
Basic Shares Outstanding
1,050
1,074
1,147
1,147
1,166
1,179
EPS (Diluted)
0.16
0.30
0.18
0.23
0.22
0.31
Diluted Shares Outstanding
1,050
1,074
1,147
1,147
1,166
1,179
EBITDA
470
607
607
601
706
751
Other Operating Expense
32
23
42
9
28
20
Non-Operating Interest Income
17
19
13
9
5
2
Minority Interest Expense
6
5
-
-
-
-

About Apeloa Pharmaceutical Co.

View Profile
Address
No. 333 Hengdianjiang South Road
Dongyang Zhejiang 322118
China
Employees -
Website http://www.apeloa.com
Updated 07/08/2019
Apeloa Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of active pharmaceutical ingredients, and drug preparation. Its products include levofloxacin hydrochloride, amantadine hydrochloride, ofloxacin, adamantane, and other pharmaceutical ingredients. It also offers capsules, ointment, granules, and injections.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.